Tycel Phillips
Associate professor in the Department of Hematology and Hematopoietic Cell Transplantation in the Division of Lymphoma at City of Hope, providing expert commentary on epcoritamab clinical trial results and lymphoma treatment strategies.
Top 3 podcasts with Tycel Phillips
Ranked by the Snipd community
Jan 30, 2026 • 9min
S15 Ep42: Long-Term Epcoritamab Data Show Durable Responses and Confirmed Safety in LBCL: With Tycel Phillips, MD
Tycel Phillips, associate professor in lymphoma and transplant at City of Hope, shares updates on long-term epcoritamab data. He discusses durability of complete responses beyond four years. He reviews safety with extended follow-up and the role of epcoritamab as a third-line option. He also highlights promising combinations pairing antibody drug conjugates with bispecifics.
Jul 22, 2024 • 12min
The role of BTK inhibitors in MCL, ongoing trials & future outlooks: updates from EHA 2024
Join experts Manali Kamdar, a leader at the University of Colorado Cancer Center, Tycel Phillips from City of Hope, and Chan Cheah of Linear Clinical Research as they dive into the transformative role of BTK inhibitors in treating mantle cell lymphoma. They discuss groundbreaking trial results, including the SHINE trial, and the significance of tumor profiling in guiding treatment for high-risk patients. The panel also explores the shift away from chemotherapy towards targeted therapies and the exciting future options such as CAR-T cells and bispecific antibodies.
Feb 2, 2023 • 11min
NHL highlights at ASH 2022: updates in MCL, the role of transplantation, and novel bispecific antibodies
Experts Michael Dickinson and Tycel Phillips discuss updates in non-Hodgkin lymphoma at ASH 2022, including the TRIANGLE trial, the changing role of transplantation, and novel immunotherapies in the field.
